Plumbagin treatment leads to apoptosis in human K562 leukemia cells through increased ROS and elevated TRAIL receptor expression

Leukemia Research

Volumn 35, Issue 10, 2011, Pages 1402-1408

  Sun, Jingping ^a   McKallip, Robert J ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; CML; ROS; TRAIL

Indexed keywords

ACETYLCYSTEINE; CATALASE; DEATH RECEPTOR 4; DEATH RECEPTOR 5; MACROGOL; PLUMBAGIN; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CELL KILLING; CELL VIABILITY; CHRONIC MYELOID LEUKEMIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG SENSITIZATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ACETYLCYSTEINE; APOPTOSIS; BLOTTING, WESTERN; CATALASE; CELL SURVIVAL; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; IN SITU NICK-END LABELING; K562 CELLS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; NAPHTHOQUINONES; OXIDATION-REDUCTION; OXIDATIVE STRESS; POLYETHYLENE GLYCOLS; REACTIVE OXYGEN SPECIES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; SIGNAL TRANSDUCTION;

EID: 80052082287     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.06.018     Document Type: Article

References (35)

1. Pitti R.M., Marsters S.A., Ruppert S., Donahue C.J., Moore A., Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996, 271(22 (May 31)):12687-12690.
2. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C.P., Nicholl J.K., et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995, 3(6 (December)):673-682.
3. El-Deiry W.S. Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling. Cell Death Differ 2001, 8(11 (November)):1066-1075.
4. Lowe S.W., Ruley H.E., Jacks T., Housman D.E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993, 74(6 (September 24)):957-967.
5. Lowe S.W., Schmitt E.M., Smith S.W., Osborne B.A., Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993, 362(6423 (April 29)):847-849.
6. Lowe S.W., Ruley H.E. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev 1993, 7(4 (April)):535-545.
7. Lowe S.W., Bodis S., McClatchey A., Remington L., Ruley H.E., Fisher D.E., et al. p53 status and the efficacy of cancer therapy in vivo. Science 1994, 266(5186 (November 4)):807-810.
8. Jin Z., El-Deiry W.S. Overview of cell death signaling pathways. Cancer Biol Ther 2005, 4(2 (February)):139-163.
9. Cheng J., Hylander B.L., Baer M.R., Chen X., Repasky E.A. Multiple mechanisms underlie resistance of leukemia cells to Apo2 Ligand/TRAIL. Mol Cancer Ther 2006, 5(7 (July)):1844-1853.
10. Kim M.J., Kim H.B., Bae J.H., Lee J.W., Park S.J., Kim D.W., et al. Sensitization of human K562 leukemic cells to TRAIL-induced apoptosis by inhibiting the DNA-PKcs/Akt-mediated cell survival pathway. Biochem Pharmacol 2009, 78(6 (September 15)):573-582.
11. MacFarlane M., Harper N., Snowden R.T., Dyer M.J., Barnett G.A., Pringle J.H., et al. Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia. Oncogene 2002, 21(44 (October 3)):6809-6818.
12. Riccioni R., Pasquini L., Mariani G., Saulle E., Rossini A., Diverio D., et al. TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL. Haematologica 2005, 90(5 (May)):612-624.
13. Hao X.S., Hao J.H., Liu F.T., Newland A.C., Jia L. Potential mechanisms of leukemia cell resistance to TRAIL-induced apopotosis. Apoptosis 2003, 8(6 (December)):601-607.
14. Testa U. TRAIL/TRAIL-R in hematologic malignancies. J Cell Biochem 2010, 110(1 (May)):21-34.
15. Chen C.Y., Tai C.J., Cheng J.T., Zheng J.J., Chen Y.Z., Liu T.Z., et al. 6-Dehydrogingerdione sensitizes human hepatoblastoma Hep G2 cells to TRAIL-induced apoptosis via reactive oxygen species-mediated increase of DR5. J Agric Food Chem 2010, 58(9 (May 12)):5604-5611.
16. Kwon D., Choi K., Choi C., Benveniste E.N. Hydrogen peroxide enhances TRAIL-induced cell death through up-regulation of DR5 in human astrocytic cells. Biochem Biophys Res Commun 2008, 372(4 (August 8)):870-874.
17. Sung B., Park B., Yadav V.R., Aggarwal B.B. Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors. J Biol Chem 2010, 285(15 (April 9)):11498-11507.
18. Inbaraj J.J., Chignell C.F. Cytotoxic action of juglone and plumbagin: a mechanistic study using HaCaT keratinocytes. Chem Res Toxicol 2004, 17(1 (January)):55-62.
19. Hsu Y.L., Cho C.Y., Kuo P.L., Huang Y.T., Lin C.C. Plumbagin induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via JNK-mediated phosphorylation at Serine 15 in vitro and in vivo. J Pharmacol Exp Ther 2006.
20. Jaiswal A.S., Bloom L.B., Narayan S. Long-patch base excision repair of apurinic/apyrimidinic site DNA is decreased in mouse embryonic fibroblast cell lines treated with plumbagin: involvement of cyclin-dependent kinase inhibitor p21Waf-1/Cip-1. Oncogene 2002, 21(38 (August 29)):5912-5922.
21. Srinivas P., Gopinath G., Banerji A., Dinakar A., Srinivas G. Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cells. Mol Carcinog 2004, 40(4 (August)):201-211.
22. McKallip R.J., Lombard C., Sun J., Ramakrishnan R. Plumbagin-induced apoptosis in lymphocytes is mediated through increased reactive oxygen species production, upregulation of Fas, and activation of the caspase cascade. Toxicol Appl Pharmacol 2010, 247(1 (August 15)):41-52.
23. Powolny A.A., Singh S.V. Plumbagin-induced apoptosis in human prostate cancer cells is associated with modulation of cellular redox status and generation of reactive oxygen species. Pharm Res 2008, 25(9 (September)):2171-2180.
24. Wang C.C., Chiang Y.M., Sung S.C., Hsu Y.L., Chang J.K., Kuo P.L. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells. Cancer Lett 2008, 259(1 (January 18)):82-98.
25. Xu K.H., Lu D.P. Plumbagin induces ROS-mediated apoptosis in human promyelocytic leukemia cells in vivo. Leuk Res 2009, 34(5 (May)):658-665.
26. Sugie S., Okamoto K., Rahman K.M., Tanaka T., Kawai K., Yamahara J., et al. Inhibitory effects of plumbagin and juglone on azoxymethane-induced intestinal carcinogenesis in rats. Cancer Lett 1998, 127(1-2 (May 15)):177-183.
27. Parimala R., Sachdanandam P. Effect of plumbagin on some glucose metabolising enzymes studied in rats in experimental hepatoma. Mol Cell Biochem 1993, 125(1 (August 11)):59-63.
28. Naresh R.A., Udupa N., Devi P.U. Niosomal plumbagin with reduced toxicity and improved anticancer activity in BALB/C mice. J Pharm Pharmacol 1996, 48(11 (November)):1128-1132.
29. Padhye S., Dandawate P., Yusufi M., Ahmad A., Sarkar F.H. Perspectives on medicinal properties of plumbagin and its analogs. Med Res Rev 2010.
30. Kawiak A., Piosik J., Stasilojc G., Gwizdek-Wisniewska A., Marczak L., Stobiecki M., et al. Induction of apoptosis by plumbagin through reactive oxygen species-mediated inhibition of topoisomerase II. Toxicol Appl Pharmacol 2007, 223(3 (September 15)):267-276.
31. Sandur S.K., Ichikawa H., Sethi G., Ahn K.S., Aggarwal B.B. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) Suppresses NF-{kappa}B activation and NF-{kappa}B-regulated gene products through modulation of p65 and I{kappa}B{alpha} kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents. J Biol Chem 2006, 281(25 (June 23)):17023-17033.
32. McCubrey J.A., Steelman L.S., Abrams S.L., Bertrand F.E., Ludwig D.E., Basecke J., et al. Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK. PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy. Leukemia 2008, 22(4 (April)):708-722.
33. Steelman L.S., Abrams S.L., Whelan J., Bertrand F.E., Ludwig D.E., Basecke J., et al. Contributions of the Raf/MEK/ERK. PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia. Leukemia 2008, 22(4 (April)):686-707.
34. Li J., Shen Q., Peng R., Chen R., Jiang P., Li Y., et al. Plumbagin enhances TRAIL-mediated apoptosis through up-regulation of death receptor in human melanoma A375 cells. J Huazhong Univ Sci Technol Med Sci 2010, 30(4 (August)):458-463.
35. Yodkeeree S., Sung B., Limtrakul P., Aggarwal B.B. Zerumbone enhances TRAIL-induced apoptosis through the induction of death receptors in human colon cancer cells: evidence for an essential role of reactive oxygen species. Cancer Res 2009, 69(16 (August 15)):6581-6589.